logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Bradley R. Corr

University of Alabama System
H指数:20
被引数:1,285

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study

MLH1启动子高甲基化及其与生存结局的关联：一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

Gynecologic Oncology
IF4.1
2026-07-010
PRE
Borden, Lindsay E.; Cosgrove, Casey M.; Washington, Christina R.; Thomas, Samantha M.; Haight, Paulina J.; Brown, Ashley; Powell, Kristina; Harsono, Adrian; Mullen, Margaret; Crafton, Sarah; Jackson, Amanda L.; Corr, Bradley R.; Wright, Jason D.; Konecny, Gottfried E.; Bae-Jump, Victoria L.; Podwika, Sarah E.; Smitherman, Carson; Maxwell, G. Larry; Backes, Floor J.; Pothuri, Bhavana; Ko, Emily M.; Arend, Rebecca C.; Thaker, Premal H.; Duska, Linda R.; Secord, Angeles Alvarez; Moore, Kathleen N.
A randomized, phase III study of sacituzumab govitecan versus treatment of physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)

一项关于sacituzumab govitecan与医生选择治疗方案在经过铂类化疗和免疫治疗后的子宫内膜癌患者中的随机、III期研究：ASCENT-GYN-01研究（GOG-3104/ENGOT-en26/APGOT-EN2）。

International Journal of Gynecological Cancer
IF4.7
2025-09-070
PRE
Ramez N. Eskander; Bradley Corr; David Cibula; David S.P. Tan; Noelle Cloven; Eva Guerra; Kosei Hasegawa; Tashanna Myers; Benoit You; Vicky Makker; Flora Zagouri; Lilian T. Gien; Michele Bartoletti; Adrianne Mallen; Linn Woelber; Simonetta Mocci; Kimberly Komatsubara; Long Ma; Nicoletta Colombo
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability

子宫内膜癌中lenvatinib与pembrolizumab联合应用的评估；一项关于实践模式、有效性和耐受性的真实世界多机构回顾。

gynecologic oncology
IF4.1
2025-08-140
PRE
Bradley R. Corr; Samantha M. Thomas; Paulina J. Haight; Elizabeth Stock; Jessica Floyd; Lindsay E. Borden; Irina Tunnage; Angeles Alvarez Secord; Rebecca Arend; Amanda L. Jackson; Jason D. Wright; Gottfried Konecny; Tara Castellano; Emily Ko; Sarah Podwika; Floor Backes; Daniel Spinosa; Margaret Mullen; Christina Washington; Bhavana Pothuri; Carson Smitherman; Alfonsus Adrian Hadikusumo Harsono; Hanaa Khadraoui; Yukio Suzuki; Ritu Salani; Kristina Powell; Shalini Subbarao; Stephanie Gaillard
A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer

一项关于rucaparib与安慰剂在转移性和复发性子宫内膜癌维持治疗中使用的II期、随机、双盲研究

gynecologic oncology
IF4.1
2025-07-220
PRE
Bradley R. Corr; Ashley Haggerty; Stefan M. Gysler; Sarah Taylor; Kian Behbakht; Jill Alldredge; Carolyn Lefkowits; Lindsay W. Brubaker; Catherine Bouts; Lisa Marie Babayan; Lainie P. Martin; James Costello; Benjamin G. Bitler; Junxiao Hu; Saketh R. Guntupalli
Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)

高肿瘤突变负荷、高微卫星不稳定性及错配修复缺陷患者的种族和族裔分子特征：多机构子宫内膜癌分子靶向治疗联盟（ECMT2）的真实世界数据

gynecologic oncology
IF4.1
2025-07-110
PRE
Sarah S. Lee; Angeles Alvarez Secord; Steven Friedman; Erinn M. Hade; Carson Smitherman; Nikita Bisht; Lindsay Borden; Amanda L. Jackson; Floor Backes; Premal Thaker; Rebecca Arend; Jason D. Wright; Bradley Corr; Emily Ko; Gottfried Konecny; Sarah Podwika; Victoria Bae-Jump; Kari E. Hacker; Bhavana Pothuri
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study

基因组改变、分子靶向治疗与生存：一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2025-05-010
PRE
Secord, Angeles Alvarez; Bae-Jump, Victoria; Backes, Floor; Thaker, Premal; Gehrig, Paola A.; Previs, Rebecca A.; Borden, Lindsay; Thomas, Samantha M.; Jackson, Amanda; Konecny, Gottfried E.; Duska, Linda R.; Arend, Rebecca; Wright, Jason; Corr, Bradley; Maxwell, G. Larry; Cosgrove, Casey M.; Mullen, Maggie M.; Washington, Christina; Herzog, Thomas J.; Cohen, Joshua; Hou, June; Gaillard, Stephanie; Fader, Amanda Nickles; Berchuck, Andrew; Pothuri, Bhavana
Randomized study evaluating optimal dose, efficacy, and safety of E7386 plus lenvatinib versus treatment of physician’s choice in advanced/recurrent endometrial carcinoma previously treated with platinum-based chemotherapy and immune checkpoint inhibitors

一项随机研究，评估E7386联合仑伐替尼相较于医师选择治疗方案，在既往接受过铂类化疗和免疫检查点抑制剂治疗的晚期/复发性子宫内膜癌患者中的最佳剂量、有效性和安全性。

International Journal of Gynecological Cancer
IF4.7
2025-04-050
PREAI
Ramez N. Eskander; Jung-Yun Lee; Mansoor Raza Mirza; Domenica Lorusso; Helen MacKay; Isabelle Ray-Coquard; Ana Oaknin; Antonio Gonzalez-Martin; Kosei Hasegawa; Bradley R. Corr; Xiaohua Wu; Alexandra Leary; Tianle Hu; Lea Dutta; Chinyere E. Okpara; Jodi McKenzie; Vicky Makker
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study

无铂间期及对复发性子宫内膜癌患者铂类再治疗或lenvatinib/pembrolizumab的应答：一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

gynecologic oncology
IF4.1
2025-03-010
PRE
Haight, Paulina J.; Sanchez, Marilyn; Thomas, Samantha M.; Smitherman, Carson; Cosgrove, Casey; Bae-Jump, Victoria; Crafton, Sarah; Hacker, Kari; Ko, Emily; Krivak, Thomas; Lara, Olivia; Moore, Kathleen; Mullen, Mary M.; Pothuri, Bhavana; Thaker, Premal H.; Washington, Christina; Arend, Rebecca; Corr, Bradley; Duska, Linda; Jackson, Amanda; Konecny, Gottfried E.; Wright, Jason; Secord, Angeles; Backes, Floor
The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third- line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial

mirvetuximab soravtansine在FRα阳性、三线及以后、复发性铂敏感卵巢癌中的疗效与安全性：单臂II期PICCOLO试验

ANNALS OF ONCOLOGY
IF65.4
2025-03-010
OAAI
Secord, A. Alvarez; Lewin, S. N.; Murphy, C. G.; Cecere, S. C.; Barquin, A.; Galvez-Montosa, F.; Mathews, C. A.; Konecny, G. E.; Ray-Coquard, I.; Oakni, A.; Perez, M. J. Rubio; Bonaventura, A.; Diver, E. J.; Ayuk, S. -M; Wang, Y.; Corr, B. R.; Salutari, V.
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258

子宫内膜癌（EC）的分子分类及其与无复发生存期（RFS）和总生存期（OS）结局的关联：GOG-0258研究的附加分析

gynecologic oncology
IF4.1
2025-02-011
PRE
Clements, Aine; Enserro, Danielle; Strickland, Kyle C.; Previs, Rebecca; Matei, Daniela; Mutch, David; Powell, Matthew; Klopp, Ann; Miller, David Scott; Small Jr, William; Disilvestro, Paul; Spirtos, Nick; Cosgrove, Casey; Sfakianos, Greg; Liu, J. Rebecca; Vargas, Roberto; Shahin, Mark; Corr, Bradley; Dessources, Kimberly; Ueland, Frederick; Warshal, David; Gillen, Jessica; Secord, Angeles Alvarez
Overall survival and mutational landscape comparison between Appalachian and non-Appalachian patients with ovarian cancer - An Oncology Research Information Network (ORIEN) analysis
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
IF3.4
2024-09-210
PRE
Swiecki-Sikora, Allison L.; Liu, Jinge; Churchman, Michelle; Liu, Jinpeng; Piecoro, Dava; Rives, Taylor A.; Nagle, Julia; Girda, Eugenia; Leiser, Aliza; Holmen, Sheri; Doherty, Jennifer; Chern, Jing-Yi; Wenham, Robert; Salhia, Bodour; Huang, Marilyn; Edge, Stephen; Holman, Laura L.; Naqash, Abdul Rafeh; Corr, Bradley; Schneider, Bryan; Wang, Chi; Dietrich, Charles S.; Kolesar, Jill M.
Mirvetuximab soravtansine (MIRV) in recurrent platinum-sensitive ovarian cancer (PSOC) with high folate receptor-alpha (FRα) expression: Results from the PICCOLO trial

Мирветуксимаб соравтансин (MIRV) 在复发铂敏感卵巢癌（PSOC）且叶酸受体-α（FRα）高表达中的应用：PICCOLO 试验的结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-015
PRE
Secord, A. A.; Corr, B. R.; Lewin, S.; Diver, E.; Ayuk, S-M.; Wang, Y.; Murphy, C.; Salutari, V.; Garcia, A. Barquin; Montosa, F. Galvez; Ray-Coquard, I. L.; Mathews, C.; Konecny, G. E.; Oaknin, A.; Perez, M. J. Rubio; Bonaventura, A.; Pignata, S.
Global, phase Ib dose-expansion cohort of E7386+lenvatinib (LEN) in patients (pts) with advanced (a) endometrial cancer (EC) that progressed on platinum-based chemotherapy (CTx) and an anti-PD-(L)1 immunotherapy (IO)

全球、Ib期剂量扩展队列研究，评估E7386联合仑伐替尼（LEN）在既往接受过铂类化疗（CTx）及抗PD-(L)1免疫疗法（IO）治疗后进展的晚期（a）子宫内膜癌（EC）患者（pts）中的疗效。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Lee, J-Y.; Hasegawa, K.; Kim, B-G.; Corr, B. R.; Kondo, S.; Suzuki, S.; Yunokawa, M.; Miller, D. S.; Tamai, T.; Dutta, L.; O'Hara, K.; Sahara, T.; Makker, V.

研究方向

暂未获取到该数据
A
Angeles Alvarez Secord
H 指数:73论文数:556被引数:4.7万
B
Bhavana Pothuri
H 指数:43论文数:449被引数:9,193
F
Floor Backes
H 指数:44论文数:363被引数:1.0万
R
Rebecca C. Arend
H 指数:44论文数:418被引数:6,608
K
Kian Behbakht
H 指数:43论文数:463被引数:9,235
J
Jason D. Wright
H 指数:81论文数:1,382被引数:2.8万
S
Saketh R. Guntupalli
H 指数:25论文数:240被引数:3,130
C
Casey Cosgrove
H 指数:18论文数:203被引数:1,640
R
Ramez N. Eskander
H 指数:37论文数:280被引数:5,855
P
Premal H. Thaker
H 指数:47论文数:767被引数:1.0万